Screening for colorectal cancer - New evidence in the last 10 years

Cancer Forum

Volumn 38, Issue 1, 2014, Pages 11-14

  Young, Graeme P ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ASCENDING COLON; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CASE CONTROL STUDY; COLONOSCOPY; COLORECTAL CANCER; FOLLOW UP; INCIDENCE; MORBIDITY; MORTALITY; OCCULT BLOOD; POLYPECTOMY; POPULATION; QUALITY CONTROL; REVIEW; SIGMOIDOSCOPY; TASK PERFORMANCE; WORLD HEALTH ORGANIZATION;

EID: 84899676268     PISSN: 0311306X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Wilson JMG, Junger G. Principles and practice of screening for disease. WHO Public Health Papers. 1968.
2. von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, Lansdorp-Vogelaar I, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013 Jan;45(1):51-9.
3. Kaminski MF, Bretthauer M, Zauber AG, Kuipers EJ, Adami HO, van Ballegooijen M, et al. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy. 2012 Jul;44(7):695-702.
4. Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010 May 13;362(19):1795-803.
5. Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer. 2004;101 (5 Suppl):1201-13. (Pubitemid 39100414)
6. Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, et al. Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network. Int J Cancer. 2012 Jun 15;130(12):2961-73.
7. Bobridge A, Cole S, Schoeman M, Lewis H, Bampton P, Young G. The National Bowel Cancer Screening Program - consequences for practice. Aust Fam Physician. 2013 Mar;42(3):141-5.
8. Fraser CG, Allison JE, Halloran SP, Young GP. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst. 2012 Jun 6;104(11):810-4.
9. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-71. (Pubitemid 23131388)
10. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar S, Balfour TW, et al. Randomised controlled trial of faecal-occult blood screening for colorectal cancer. Lancet. 1996;348:1472-7. (Pubitemid 26400242)
11. Kronborg O, Fenger C, Olsen J, Jorgenson OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-ocultblood test. Lancet. 1996;348:1467-71. (Pubitemid 26400241)
12. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434-7. (Pubitemid 29128279)
13. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126:1674-80. (Pubitemid 38736331)
14. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-7. (Pubitemid 32162983)
15. Young GP, Allison J. Screening for colorectal cancer. In: Yamada T, Alpers D, Kaplowitz N, Laine L, Owyang C, Powell D, editors. Textbook of Gastroenterology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2008. p. 170-82.
16. Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006;107:2152-9. (Pubitemid 44665648)
17. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomized trial of the impact of new fecal hemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen. 2003;10:117-22. (Pubitemid 38296846)
18. Lane JM, Chow E, Young GP, Good N, Smith A, Bull J, et al. Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia. Gastroenterology. 2010 Dec;139(6):1918-26.
19. Hiwatashi N, Morimoto T, Fukao A, Sato H, Sugahara N, Hisamichi S et al. An evaluation of mass screening using faecal occult blood test for colorectal cancer in Japan. Jpn J Cancer Res. 1993;84:1110-2. (Pubitemid 23351001)
20. Saito H, Soma Y, Koeda J, Wada T, Kawaguchi H, Sobue T, et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test- A case-control study. Int J Cancer. 1995;61:465-9.
21. Zappa M, Castiglione G, Grazzini G, Falini P, Giorgi D, Paci E, et al. Effect of fecal occult blood testing on colorectal mortality. Results of a population-based case-control study in the district of Florence, Italy. Int J Cancer. 1997;73:208-10. (Pubitemid 27448820)
22. Saito H, Soma Y, Nakajima M, Koeda J, Kawaguchi H, Kakizaki R, et al. A case-control study evaluating occult blood screening for colorectal cancer with Hemoccult test and an immunochemical hemagglutination. Oncol Rep. 2000;7:815-9.
23. Nakajima M, Saito H, Soma Y, Sobue T, Tanaka M, Munakata A. Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a case-control study. Br J Cancer. 2003;89:23-8. (Pubitemid 36897930)
24. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: A prospective cohort study in Japan. Cancer Detect Prev. 2007;31:3-11. (Pubitemid 46367446)
25. Saito H, Soma Y, Nakajima M, Koeda J, Kawaguchi H, Kakizaki R, et al. Screening for colorectal cancer: current status in Japan. Dis Colon Rectum. 2000;43:S78-84.
26. Oort FA, Terhaar Sive Droste JS, Van Der Hulst RW, Van Heukelem HA, Loffeld RJ, Wesdorp IC, et al. Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test. Aliment Pharmacol Ther. 2010 Feb 1;31(3):432-9.
27. vanRossum LG, vanRijn AF, Laheij RJ, vanOijen MG, Fockens P, vanKrieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood test for coloretcal cancer in a screening population. Gastroenterology. 2008;135:82-90. (Pubitemid 351899018)
28. Young GP, Cole SR. Which fecal occult blood test is best for colorectal cancer screening? Nat Clin Pract Gastroenterol Hepatol. 2009;6:140-1.
29. de Wijkerslooth TR, de Haan MC, Stoop EM, Bossuyt PM, Thomeer M, van Leerdam ME, et al. Reasons for participation and nonparticipation in colorectal cancer screening: a randomized trial of colonoscopy and CT colonography. Am J Gastroenterol. 2012 Dec;107(12):1777-83.
30. Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009 Apr 7;100(7):1103-10.
31. Cole SR, Tucker GR, Osborne JM, Byrne SE, Bampton PA, Fraser RJ, et al. Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program. Med J Aust. 2013 Apr 1;198(6):327-30.
32. Ananda SS, McLaughlin SJ, Chen F, Hayes IP, Hunter AA, Skinner IJ, et al. Initial impact of Australia's National Bowel Cancer Screening Program. Med J Aust. 2009 Oct 5;191(7):378-81.
33. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010 May 8;375(9726):1624-33.
34. Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial - SCORE. J Natl Cancer Inst. 2011 Sep 7;103(17):1310-22.
35. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012 Jun 21;366(25):2345-57.
36. Sillars-Hardebol AH, Carvalho B, van Engeland M, Fijneman RJ, Meijer GA. The adenoma hunt in colorectal cancer screening: defining the target. J Pathol. 2012 Jan;226(1):1-6.
37. Lakoff J, Paszat LF, Saskin R, Rabeneck L. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol. 2008 Oct;6(10):1117-21; quiz 064.
38. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of Colonoscopy and Death From Colorectal Cancer. Ann Intern Med. 2009;150:1-8.
39. Singh H, Nugent Z, Demers AA, Bernstein CN. Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol. 2010 Dec;105(12):2588-96.
40. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst. 2010 Jan 20;102(2):89-95.
41. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med. 2011 Jan 4;154(1):22-30.
42. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. American Cancer Society Colorectal Cancer Advisory Group. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570-95. (Pubitemid 351615355)
43. Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. 2013 Feb 13.
44. Cole SR, Smith A, Wilson C, Turnbull D, Esterman A, Young GP. An advance notification letter increases participation in colorectal cancer screening. J Med Screen. 2007;14(2):73-5. (Pubitemid 47067760)
45. Roslani AC, Abdullah T, Arumugam K. Screening for colorectal neoplasias with fecal occult blood tests: false-positive impact of non-dietary restriction. Asian Pac J Cancer Prev. 2012;13(1):237-41.
46. Zajac IT, Whibley AH, Cole SR, Byrne D, Guy J, Morcom J, et al. Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: a longitudinal analysis. J Med Screen. 2010;17(1):19-24.